ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

9473	Companies
185399	Keywords
117755	Articles
99281	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 07/24/2025 at 14:40, 4 months 11 days ago

Abivax announces trading resumption of its ordinary shares on Euronext Paris
Abivax announces the trading resumption of its ordinary shares on Euronext Paris after a temporary halt for a public offering confirmation and pricing announcement

Euronext Paris Abivax Public Offering Clinical-stage Biotechnology Trading Resumption
PRESS RELEASE

published on 07/24/2025 at 14:40, 4 months 11 days ago

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
Abivax announces pricing of $650M (€554M) public offering of American Depositary Shares to fund clinical development and working capital, with expected closing on July 28, 2025

Abivax Clinical Development Public Offering Pricing Closing
BRIEF

published on 07/24/2025 at 07:35, 4 months 12 days ago

Abivax Temporarily Halts Trading on Euronext Paris

Euronext Paris Biotechnology Abivax Trading Halt Public Offering
PRESS RELEASE

published on 07/24/2025 at 07:30, 4 months 12 days ago

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris due to public offering preparations

Euronext Paris Abivax Trading Halt Public Offering Clinical-stage Biotechnology
BRIEF

published on 07/23/2025 at 22:20, 4 months 12 days ago

Abivax Launches $400 Million Public Offering

Ulcerative Colitis Clinical Development Capital Market Abivax Public Offering Biotechnology Financing
PRESS RELEASE

published on 07/23/2025 at 22:15, 4 months 12 days ago

Abivax Announces Launch of Public Offering
Abivax announces launch of $400 million public offering to fund therapeutics for chronic inflammatory diseases. Underwritten by Leerink Partners, Piper Sandler, Guggenheim Securities, with LifeSci Capital, BTIG, Van Lanschot Kempen as managers

Biotechnology Financing Abivax Underwriters Public Offering
BRIEF

published on 07/22/2025 at 22:10, 4 months 13 days ago

Abivax Announces Positive Phase 3 Results for Obefazimod in Ulcerative Colitis

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials MiR-124 Enhancer
PRESS RELEASE

published on 07/22/2025 at 22:05, 4 months 13 days ago

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
Abivax announces positive Phase 3 results for obefazimod in ulcerative colitis trials, meeting key endpoints and demonstrating favorable tolerability. Conference call scheduled for more insights

Abivax Obefazimod Ulcerative Colitis Clinical Trials Phase 3 Results
BRIEF

published on 07/17/2025 at 18:05, 4 months 18 days ago

ABIVAX: Details on share capital and voting rights

Share Capital Voting Rights Investors Abivax Number Of Shares
BRIEF

published on 06/19/2025 at 18:05, 5 months 15 days ago

ABIVAX Declares the Composition of its Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights Abivax AMF Regulations

Accesswire

Published on 12/05/2025 at 02:35, 6 hours 17 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 22 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 52 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 47 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 52 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:30, 21 minutes ago

Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 22 minutes ago

Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 46 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 51 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 51 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

Les Echos

Published on 12/05/2025 at 08:45, 7 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 14 hours 52 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 7 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 8 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE